BRIEF published on 06/30/2025 at 14:05, 10 months 29 days ago Promising Phase 1b Results for invIOs's APN401 Cell Therapy in Advanced Tumors Cell Therapy Phase 1b Trial InvIOs GmbH APN401 Advanced Tumors
BRIEF published on 06/30/2025 at 14:05, 10 months 29 days ago Résultats prometteurs de phase 1b pour la thérapie cellulaire APN401 d'invIOs dans les tumeurs avancées Thérapie Cellulaire InvIOs GmbH APN401 Essai De Phase 1b Tumeurs Avancées
PRESS RELEASE published on 06/30/2025 at 14:00, 10 months 29 days ago invIOs reports promising Phase 1b results for cell therapy APN401 in advanced solid tumors invIOs reports successful Phase 1b trial results for APN401 cell therapy in advanced solid tumors, showing safety and efficacy in late-stage cancer patients Solid Tumors Cell Therapy Phase 1b Trial InvIOs APN401
BRIEF published on 12/16/2024 at 15:05, 1 year 5 months ago InvIOs to Highlight Oncology Pipeline Progress at JP Morgan Week 2025 Oncology Cancer Research Cell Therapy Glioblastoma InvIOs GmbH
BRIEF published on 12/16/2024 at 15:05, 1 year 5 months ago InvIOs mettra en avant les progrès du pipeline oncologique lors de la JP Morgan Week 2025 Thérapie Cellulaire Oncologie Glioblastome Recherche Sur Le Cancer InvIOs GmbH
PRESS RELEASE published on 12/16/2024 at 15:00, 1 year 5 months ago invIOs to present progress across oncology pipeline during JP Morgan Week 2025 invIOs GmbH to present progress in oncology pipeline at JP Morgan Week 2025, including updates on glioblastoma treatments INV501 and INV441 in collaboration with DFCI Oncology Pipeline InvIOs GmbH JP Morgan Week 2025 Glioblastoma Treatments DFCI Collaboration
BRIEF published on 10/15/2024 at 10:35, 1 year 7 months ago InvIOs Secures €8.2 Million Series A Funding for Immuno-oncology Innovations Biotechnology Fundraising Clinical Trials Immuno-oncology InvIOs GmbH
BRIEF published on 10/15/2024 at 10:35, 1 year 7 months ago InvIOS obtient un financement de série A de 8,2 millions d'euros pour des innovations en immuno-oncologie Biotechnologie Essais Cliniques Immuno-oncologie Collecte De Fonds InvIOs GmbH
PRESS RELEASE published on 10/15/2024 at 10:30, 1 year 7 months ago invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology invIOs GmbH raises €8.2 million in Series A funding to advance immuno-oncology pipeline progress through 2025, collaborating with Dana-Farber Cancer Institute Series A Funding Immuno-oncology Pipeline Progress InvIOs Dana-Farber Cancer Institute
BRIEF published on 07/17/2024 at 10:05, 1 year 10 months ago InvIOs Selects INV501 Lead Candidate for IND-Enabling Studies in Glioblastoma and Melanoma Cancer Therapy Melanoma Preclinical Studies INV501 Glioblastoma
Published on 05/29/2026 at 15:50, 3 hours 56 minutes ago Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million
Published on 05/29/2026 at 14:30, 5 hours 16 minutes ago Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Published on 05/29/2026 at 14:30, 5 hours 16 minutes ago Unusual Machines to Participate in June Investor Conferences
Published on 05/29/2026 at 14:20, 5 hours 26 minutes ago Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Published on 05/29/2026 at 13:59, 5 hours 47 minutes ago AIP Realty Trust Announces First Quarter 2026 Results
Published on 05/29/2026 at 19:27, 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/29/2026 at 19:18, 28 minutes ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Change to the shareholding structure
Published on 05/29/2026 at 18:50, 56 minutes ago EQS-Adhoc: fox e-mobility AG: Capital Increase and Debt Reduction at Fox Automotive Switzerland AG – Adjustment of Shareholding Value – Departure of Philippe Perret – Financial Reports – Annual General Meeting D
Published on 05/29/2026 at 18:30, 1 hour 16 minutes ago EPIC Suisse AG: EPIC Suisse divests Vennes III property in Lausanne
Published on 05/29/2026 at 18:00, 1 hour 46 minutes ago Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV
Published on 05/29/2026 at 18:00, 1 hour 46 minutes ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 15:38, 4 hours 8 minutes ago Déclaration d'actions et de droits de vote au 30.04.2026
